What We're Reading: Page 340
Industry reads hand-picked by our editors
May 16, 2016
-
FiveThirtyEight
Theranos Is Wrong: We Don’t Need More Blood Tests
-
AP
Vermont to require drug makers to explain price increases
-
New York Times
Scientists Talk Privately About Creating a Synthetic Human Genome
-
Compare-Trials
Annals update protocol sharing requirements for trialists, after COMPare finds shortcomings
May 13, 2016
-
The Washington Post
Secret rebates, coupons and exclusions: How the battle over high drug prices is really being fought
-
The Verge
People used a journalism database to search for drugs
-
Stat
Why a FDA plan to find compassionate-use drugs may be a Band-Aid
-
CNN
Opioid history: From 'wonder drug' to abuse epidemic
May 12, 2016
-
BloombergGadfly
Pharma's Game of (Hep C) Thrones
-
Reuters
AstraZeneca drug wins orphan status in thyroid cancer
-
PharmaTimes
BMS bags two EU nods, for Empliciti and Opdivo/Yervoy
-
Food Dive
FDA posts final medical foods guidance amid category surge
May 11, 2016
-
HuffPost Business
Meet health care's major spoilers: Theranos, Valeant and Turing Pharmaceuticals
-
Stat
US senator introduces a 'Right to Try' bill for desperate patients
-
The New York Times
Change is in the air for pharmaceutical mergers
-
Research and Markets (via Business Wire)
Global contract pharmaceutical manufacturing market worth $84 billion by 2020
-
The Des Moines Register
Treating biopharma as 'boogeyman' is not the answer
May 10, 2016
May 09, 2016
-
Bloomberg
Valeant Reiterates Quarterly Outlook, Sees Filing on Time
-
Reuters
Gates Foundation backs Takeda polio vaccine with $38 million grant
-
LA Times
Purdue Pharma issues statement on OxyContin report; L.A. Times responds
-
Reuters
China regulator to launch probe into foreign, local drug firms: China Daily
May 06, 2016
-
Wall Street Journal
Knockoffs of Biotech Drugs Bring Paltry Savings
-
The Economist
Encore une fois
-
LA Times
'You Want a Description of Hell?' Oxycontin's 12-Hour Problem
-
Bloomberg
Glaxo’s CEO Search Will Be ‘Relatively Expensive,’ Chairman Says
Previous
